[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4654 Introduced in House (IH)]

103d CONGRESS
  2d Session
                                H. R. 4654

To amend title XVIII of the Social Security Act to provide for coverage 
under part B of the medicare program of drugs approved by the Food and 
  Drug Administration for the treatment of individuals with multiple 
                               sclerosis.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             June 27, 1994

Mr. Greenwood introduced the following bill; which was referred jointly 
      to the Committees on Ways and Means and Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To amend title XVIII of the Social Security Act to provide for coverage 
under part B of the medicare program of drugs approved by the Food and 
  Drug Administration for the treatment of individuals with multiple 
                               sclerosis.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MEDICARE COVERAGE OF DRUGS FOR TREATMENT OF INDIVIDUALS WITH 
              MULTIPLE SCLEROSIS.

    (a) In General.--Section 1861(s)(2) of the Social Security Act (42 
U.S.C. 1395x(s)(2)), as amended by section 13553(a) of the Omnibus 
Budget Reconciliation Act of 1993, is amended--
                    (1) by striking ``and'' at the end of subparagraph 
                (P);
                    (2) by adding ``and'' at the end of subparagraph 
                (Q); and
                    (3) by adding at the end the following new 
                subparagraph:
            ``(R) a drug for the treatment of individuals with multiple 
        sclerosis (if the use of the drug for such purpose is approved 
        by the Food and Drug Administration);''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
apply to drugs furnished on or after January 1, 1995.

                                 <all>